Evidence map›Paper›PMID 31025548›Full record

ArticleCancer medicine2019

Syncytin 1, CD9, and CD47 regulating cell fusion to form PGCCs associated with cAMP/PKA and JNK signaling pathway.

Fei Fei, Chunyuan Li, Xinlu Wang, Jiaxing Du, Kai Liu, Bo Li, Peiyu Yao, Yuwei Li, Shiwu Zhang

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Implications of Heterotypic Cell Fusion in Cancer.Advances in experimental medicine and biology · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Cell-cell fusion in cancer: The next cancer hallmark?The international journal of biochemistry & cell biology · 2024
    Review
  11. Review
  12. Surviving the Storm: The Role of Poly- and Depolyploidization in Tissues and Tumors.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  13. Article
  14. Cell Fusion and Syncytia Formation in Cancer.Results and problems in cell differentiation · 2024
    Review
  15. Article
  16. Intrinsic signalling factors associated with cancer cell-cell fusion.Cell communication and signaling : CCS · 2023
    Review
  17. Review
  18. Article
  19. Extracellular Events Involved in Cancer Cell-Cell Fusion.International journal of molecular sciences · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Fei FeiSchool of Medicine, Nankai University, Tianjin, P.R. China.
Chunyuan LiSchool of Medicine, Nankai University, Tianjin, P.R. China.
Xinlu WangGraduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, P.R. China.
Jiaxing DuGraduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, P.R. China.
Kai LiuTianjin Medical University, Tianjin, P.R. China.
Bo LiGraduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, P.R. China.
Peiyu YaoDepartment of Pathology, Tianjin Union Medical Center, Tianjin, P.R. China.
Yuwei LiDepartment of colorectal surgery, Tianjin Union Medical Center, Tianjin, P.R. China.
Shiwu ZhangSchool of Medicine, Nankai University, Tianjin, P.R. China.ORCID 0000-0002-5052-2283
Nankai University · CNTianjin University of Traditional Chinese Medicine · CNTianjin People's Hospital · CNTianjin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe have previously reported the formation of polyploid giant cancer cells (PGCCs) through endoreduplication or cell fusion after cobalt chloride (CoCl

methodsWe treat HCT116 and LoVo cell with CoCl

resultsThe expression of syncytin 1, CD9, and CD47 is higher in PGCCs than in control cells and they are located in the cytoplasm. The expression of PKA RIα and JNK1 decreased, and that of c-Jun increased in PGCCs. The syncytin 1 expression was significantly different between groups I and II (P = 0.000), groups III and IV (P = 0.000), groups V and VI (P = 0.029), groups I and III (P = 0.001), groups III and V (P = 0.000), and groups I, III, and V (P = 0.000).

conclusionsThese data indicate that the cell fusion-related proteins syncytin 1, CD9, and CD47 may be involved in PGCC formation, and that cAMP/PKA and JNK signaling is likely to promote PGCC formation via the regulation of cell fusion processes.

Indexed as

MAP Kinase Signaling SystemCD47 AntigenCell DifferentiationCell FusionCell Line, TumorCobaltColorectal NeoplasmsCyclic AMP-Dependent Protein KinasesGene Products, envGiant CellsHCT116 CellsHumansPolyploidyPregnancy ProteinsTetraspanin 29CD47 AntigenCD47 protein, humanCD9 protein, humanCobaltcobaltous chlorideCyclic AMP-Dependent Protein KinasesGene Products, envPregnancy ProteinssyncytinTetraspanin 29cell fusioncolorectal cancerpolyploid giant cancer cellssyncytin 1

Identifiers

PMID31025548
PMCPMC6558479
OpenAlexW2941830556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.